+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumococcal Testing Market by Type Of Test (Culture Based, Molecular, Serological), Technology (Elisa, Immunochromatographic Test, Next-Generation Sequencing), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Pneumococcal Testing Market by Type Of Test (Culture Based, Molecular, Serological), Technology (Elisa, Immunochromatographic Test, Next-Generation Sequencing), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Pneumococcal Testing Market by Type Of Test (Culture Based, Molecular, Serological), Technology (Elisa, Immunochromatographic Test, Next-Generation Sequencing), Application, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336733
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pneumococcal Testing Market is undergoing notable transformation, driven by technological progress, changing regulatory conditions, and evolving clinical requirements. These factors are shaping how healthcare providers, laboratories, and stakeholders respond to increasing complexities in infectious disease diagnostics.

Pneumococcal Testing Market Snapshot

The global pneumococcal testing market grew from USD 1.80 billion in 2024 to USD 1.97 billion in 2025. With a projected CAGR of 9.02%, the market is expected to reach USD 3.03 billion by 2030, reflecting strong demand for advanced diagnostics and adaptive laboratory solutions.

Scope & Segmentation of the Pneumococcal Testing Market

This report provides in-depth coverage of pivotal market segments and technology platforms, highlighting opportunities and challenges across various regions and end-user environments. The study addresses the following segmentation areas:

  • Type of Test: Automated culture, conventional culture, digital PCR, multiplex PCR, real time PCR, ELISA, rapid immunoassay.
  • Technologies: Indirect ELISA, sandwich ELISA, dot blot, lateral flow assay, next-generation sequencing (Illumina, Ion Torrent), PCR assay modalities.
  • Applications: Carrier screening (nasopharyngeal, oropharyngeal), diagnosis (community-acquired pneumonia, meningitis, otitis media), surveillance (antibiotic resistance monitoring, serotype distribution), vaccine evaluation (post-marketing surveillance, preclinical trials).
  • End Users: Community health centers, outpatient clinics, large and small hospitals, local and state public health laboratories, national and regional reference labs.
  • Distribution Channels: Direct sales, specialty sales teams, local and national distributors, ecommerce platforms, manufacturer portals.
  • Regions Covered: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Russia, UAE, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, among others).
  • Company Developments: Major participants include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific Inc., QIAGEN N.V., Hologic, Inc., Bio-Rad Laboratories, Inc., Seegene Inc., and Meridian Bioscience Inc.

Key Takeaways for Senior Decision-Makers

  • The market’s evolution is significantly influenced by the integration of molecular diagnostics, digital PCR, and next-generation sequencing, raising expectations for faster, more precise results in both clinical and surveillance applications.
  • Healthcare providers are adopting point of care immunoassays and modular testing platforms to streamline operations, improve patient access, and address evolving testing needs at the community level.
  • Shifting regulatory and reimbursement frameworks are aligning with precision diagnostics, prompting industry stakeholders to adapt commercialization and partnership strategies for long-term sustainability.
  • The emergence of new competitors, regional expansion, and collaborative alliances are reshaping the competitive landscape and driving innovation in reagent and platform design.
  • Global trends highlight divergent regional priorities: established regions invest in advanced screening and surveillance technologies, whereas emerging regions focus on cost-effective, high-impact solutions for essential healthcare needs.
  • Proactive scenario planning and strategic supply chain management are critical as market participants confront global uncertainties and regulatory fluctuations.

Tariff Impact: Addressing US Regulatory Shifts in 2025

The introduction of new United States tariffs on diagnostic reagents and instrumentation in 2025 has substantially increased input costs for laboratories and small clinics relying on international suppliers. This policy adjustment has encouraged domestic manufacturing partnerships and led to innovation in assay design and reagent formulation, as developers look to minimize supply chain vulnerabilities and platform dependency.

Pneumococcal Testing Market Methodology & Data Sources

This analysis employs a mixed-method research approach, integrating secondary research from peer-reviewed journals, regulatory databases, and financial disclosures with targeted interviews of industry experts and laboratory leaders. Triangulation techniques and analytical frameworks, including competitive and PESTLE analysis, ensure data reliability and relevance.

Why This Report Matters for Strategic Planning

  • Enables evidence-based decision making through actionable insights on product, technology, and market entry strategies.
  • Supports risk mitigation by providing detailed analysis of regional differences, tariff impacts, and competitive shifts in pneumococcal diagnostics.
  • Equips senior leaders and stakeholders to identify growth opportunities and align resources with emerging trends in clinical and public health testing.

Conclusion

The pneumococcal testing market is experiencing dynamic change, propelled by evolving diagnostics and regulatory shifts. Informed, agile strategies and collaboration remain essential for stakeholders to capture emerging opportunities and support global health objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiplex molecular assays for rapid differentiation of pneumococcal serotypes and co-circulating respiratory pathogens
5.2. Expansion of point-of-care polymerase chain reaction testing for pneumococcal detection in underserved and resource-limited settings
5.3. Adoption of next-generation sequencing for high-resolution surveillance of pneumococcal strain diversity and antibiotic resistance profiles
5.4. Development of automated sample-to-answer platforms to accelerate pneumococcal testing workflows in hospital and clinical laboratory settings
5.5. Implementation of cloud-based data analytics and digital reporting tools for real-time monitoring of pneumococcal infection outbreaks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pneumococcal Testing Market, by Type Of Test
8.1. Introduction
8.2. Culture Based
8.2.1. Automated Culture
8.2.2. Conventional Culture
8.3. Molecular
8.3.1. Digital PCR
8.3.2. Multiplex PCR
8.3.3. Real Time PCR
8.4. Serological
8.4.1. Elisa
8.4.2. Rapid Immunoassay
9. Pneumococcal Testing Market, by Technology
9.1. Introduction
9.2. Elisa
9.2.1. Indirect Elisa
9.2.2. Sandwich Elisa
9.3. Immunochromatographic Test
9.3.1. Dot Blot
9.3.2. Lateral Flow Assay
9.4. Next-Generation Sequencing
9.4.1. Illumina Platform
9.4.2. Ion Torrent
9.5. Pcr Assay
9.5.1. Digital PCR
9.5.2. Multiplex PCR
9.5.3. Real Time PCR
10. Pneumococcal Testing Market, by Application
10.1. Introduction
10.2. Carrier Screening
10.2.1. Nasopharyngeal Screening
10.2.2. Oropharyngeal Screening
10.3. Diagnosis
10.3.1. Community Acquired Pneumonia
10.3.2. Meningitis
10.3.3. Otitis Media
10.4. Surveillance
10.4.1. Antibiotic Resistance Monitoring
10.4.2. Serotype Distribution
10.5. Vaccine Evaluation
10.5.1. PostMarketing Surveillance
10.5.2. PreClinical Trials
11. Pneumococcal Testing Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Community Health Centers
11.2.2. Outpatient Clinics
11.3. Hospitals
11.3.1. Large Hospitals
11.3.2. Small Hospitals
11.4. Public Health Labs
11.4.1. Local Public Health Labs
11.4.2. State Public Health Labs
11.5. Reference Labs
11.5.1. National Reference Labs
11.5.2. Regional Reference Labs
12. Pneumococcal Testing Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. Online Direct
12.2.2. Specialty Sales Team
12.3. Distributors
12.3.1. Local Distributors
12.3.2. National Distributors
12.4. Online
12.4.1. Ecommerce Platforms
12.4.2. Manufacturer Portals
13. Americas Pneumococcal Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pneumococcal Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pneumococcal Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Becton, Dickinson and Company
16.3.4. bioMérieux SA
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. QIAGEN N.V.
16.3.7. Hologic, Inc.
16.3.8. Bio-Rad Laboratories, Inc.
16.3.9. Seegene Inc.
16.3.10. Meridian Bioscience Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PNEUMOCOCCAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PNEUMOCOCCAL TESTING MARKET: RESEARCHAI
FIGURE 26. PNEUMOCOCCAL TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. PNEUMOCOCCAL TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. PNEUMOCOCCAL TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PNEUMOCOCCAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AUTOMATED CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AUTOMATED CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DOT BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DOT BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ILLUMINA PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ILLUMINA PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ION TORRENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NASOPHARYNGEAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NASOPHARYNGEAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OROPHARYNGEAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OROPHARYNGEAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANTIBIOTIC RESISTANCE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANTIBIOTIC RESISTANCE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROTYPE DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROTYPE DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POSTMARKETING SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POSTMARKETING SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRECLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRECLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL PUBLIC HEALTH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL PUBLIC HEALTH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE PUBLIC HEALTH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE PUBLIC HEALTH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL REFERENCE LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL REFERENCE LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGIONAL REFERENCE LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGIONAL REFERENCE LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SPECIALTY SALES TEAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SPECIALTY SALES TEAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 265. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2024 (USD MILLION)
TABLE 266. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025-2030 (USD MILLION)
TABLE 267. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
TABLE 268. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2025-2030 (USD MILLION)
TABLE 269. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 270. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 271. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 272. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 273. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 276. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 277. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2024 (USD MILLION)
TABLE 278. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2025-2030 (USD MILLION)
TABLE 279. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 280. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 281. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2024 (USD MILLION)
TABLE 282. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2025-2030 (USD MILLION)
TABLE 283. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2024 (USD MILLION)
TABLE 286. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2025-2030 (USD MILLION)
TABLE 287. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 288. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 289. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 290. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 291. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2024 (USD MILLION)
TABLE 292. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2025-2030 (USD MILLION)
TABLE 293. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 298. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 299. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2024 (USD MILLION)
TABLE 300. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2025-2030 (USD MILLION)
TABLE 301. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2024 (USD MILLION)
TABLE 302. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2025-2030 (USD MILLION)
TABLE 303. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 306. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 307. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 308. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 309. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 310. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 311. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2024 (USD MILLION)
TABLE 312. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025-2030 (USD MILLION)
TABLE 313. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
TABLE 314. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2025-2030 (USD MILLION)
TABLE 315. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 316. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 317. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 318. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 319. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 320. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 321. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 322. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 323. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2024 (USD MILLION)
TABLE 324. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2025-2030 (USD MILLION)
TABLE 325. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 326. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 327. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2024 (USD MILLION)
TABLE 328. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2025-2030 (USD MILLION)
TABLE 329. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pneumococcal Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • Seegene Inc.
  • Meridian Bioscience Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.03 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides - Product Image

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides

  • Report
  • 606 Pages
  • Global
From
Juvenile Idiopathic Arthritis Diagnostic Market by Product Type (Imaging Diagnostics, Laboratory Diagnostics), Technology (ELISA, Flow Cytometry, PCR Technology), End User, Test Type - Global Forecast 2025-2030 - Product Image

Juvenile Idiopathic Arthritis Diagnostic Market by Product Type (Imaging Diagnostics, Laboratory Diagnostics), Technology (ELISA, Flow Cytometry, PCR Technology), End User, Test Type - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Toxoplasma Gondii Recombinant Antigen Market by Product Type (Elisa Kit, Rapid Test Kit, Western Blot Kit), Application (Clinical Diagnosis, Research Use, Veterinary Diagnosis), End User, Technology - Global Forecast 2025-2030 - Product Image

Toxoplasma Gondii Recombinant Antigen Market by Product Type (Elisa Kit, Rapid Test Kit, Western Blot Kit), Application (Clinical Diagnosis, Research Use, Veterinary Diagnosis), End User, Technology - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
STD Diagnostics Market Size, Share & Trends Analysis Report by Application (HIV Testing, HSV Testing, Chlamydia Testing), Product, Technology, Location of Testing, and Region with Growth Forecasts, 2025-2030 - Product Image

STD Diagnostics Market Size, Share & Trends Analysis Report by Application (HIV Testing, HSV Testing, Chlamydia Testing), Product, Technology, Location of Testing, and Region with Growth Forecasts, 2025-2030

  • Report
  • 156 Pages
  • Global
From
Norovirus Diagnostics - Global Strategic Business Report - Product Image

Norovirus Diagnostics - Global Strategic Business Report

  • Report
  • 132 Pages
  • Global
From

About the Market

The Pneumococcal Test is a diagnostic tool used to detect the presence of Streptococcus pneumoniae, a bacterium that can cause a range of illnesses, including pneumonia, meningitis, and sepsis. The test is typically performed on a sample of blood, sputum, or cerebrospinal fluid, and can be used to diagnose an infection, determine the severity of the infection, and monitor the effectiveness of treatment. The Pneumococcal Test market is a subset of the larger Diagnostics market, which includes a range of tests used to diagnose and monitor a variety of medical conditions. The Pneumococcal Test market is driven by the increasing prevalence of pneumococcal infections, as well as the need for accurate and timely diagnosis and treatment. Some companies in the Pneumococcal Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.